223 related articles for article (PubMed ID: 30146065)
21. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
22. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
23. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
Lai KKY; Kweon SM; Chi F; Hwang E; Kabe Y; Higashiyama R; Qin L; Yan R; Wu RP; Lai K; Fujii N; French S; Xu J; Wang JY; Murali R; Mishra L; Lee JS; Ntambi JM; Tsukamoto H
Gastroenterology; 2017 May; 152(6):1477-1491. PubMed ID: 28143772
[TBL] [Abstract][Full Text] [Related]
24. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
25. Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities.
Piguet AC; Majumder S; Maheshwari U; Manjunathan R; Saran U; Chatterjee S; Dufour JF
Clin Sci (Lond); 2014 Jun; 126(11):775-84. PubMed ID: 24283268
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma.
Seitz T; Freese K; Dietrich P; Thasler WE; Bosserhoff A; Hellerbrand C
Sci Rep; 2020 Mar; 10(1):4546. PubMed ID: 32161315
[TBL] [Abstract][Full Text] [Related]
27. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-induced secretion of platelet-derived growth factor-BB by hepatocellular carcinoma cells increases activated hepatic stellate cell proliferation, migration and expression of vascular endothelial growth factor-A.
Lu Y; Lin N; Chen Z; Xu R
Mol Med Rep; 2015 Jan; 11(1):691-7. PubMed ID: 25333351
[TBL] [Abstract][Full Text] [Related]
29. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis.
Wang BB; Cheng JY; Gao HH; Zhang Y; Chen ZN; Bian H
Anat Rec (Hoboken); 2010 Sep; 293(9):1492-6. PubMed ID: 20652939
[TBL] [Abstract][Full Text] [Related]
30. Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis.
DePeralta DK; Wei L; Ghoshal S; Schmidt B; Lauwers GY; Lanuti M; Chung RT; Tanabe KK; Fuchs BC
Cancer; 2016 Apr; 122(8):1216-27. PubMed ID: 26914713
[TBL] [Abstract][Full Text] [Related]
31. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
[TBL] [Abstract][Full Text] [Related]
32. Sox9/INHBB axis-mediated crosstalk between the hepatoma and hepatic stellate cells promotes the metastasis of hepatocellular carcinoma.
Chen Y; Qian B; Sun X; Kang Z; Huang Z; Ding Z; Dong L; Chen J; Zhang J; Zang Y
Cancer Lett; 2021 Feb; 499():243-254. PubMed ID: 33246092
[TBL] [Abstract][Full Text] [Related]
33. Hepatic Stellate Cell-Specific Platelet-Derived Growth Factor Receptor-α Loss Reduces Fibrosis and Promotes Repair after Hepatocellular Injury.
Kikuchi A; Singh S; Poddar M; Nakao T; Schmidt HM; Gayden JD; Sato T; Arteel GE; Monga SP
Am J Pathol; 2020 Oct; 190(10):2080-2094. PubMed ID: 32615075
[TBL] [Abstract][Full Text] [Related]
34. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma.
Amann T; Bataille F; Spruss T; Mühlbauer M; Gäbele E; Schölmerich J; Kiefer P; Bosserhoff AK; Hellerbrand C
Cancer Sci; 2009 Apr; 100(4):646-53. PubMed ID: 19175606
[TBL] [Abstract][Full Text] [Related]
35. Hepatic Stellate Cell: A Potential Target for Hepatocellular Carcinoma.
Wu M; Miao H; Fu R; Zhang J; Zheng W
Curr Mol Pharmacol; 2020; 13(4):261-272. PubMed ID: 32091349
[TBL] [Abstract][Full Text] [Related]
36. Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development.
Sung YC; Liu YC; Chao PH; Chang CC; Jin PR; Lin TT; Lin JA; Cheng HT; Wang J; Lai CP; Chen LH; Wu AY; Ho TL; Chiang T; Gao DY; Duda DG; Chen Y
Theranostics; 2018; 8(4):894-905. PubMed ID: 29463989
[TBL] [Abstract][Full Text] [Related]
37. Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma.
Nguyen PT; Kanno K; Pham QT; Kikuchi Y; Kakimoto M; Kobayashi T; Otani Y; Kishikawa N; Miyauchi M; Arihiro K; Ito M; Tazuma S
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3255-3268. PubMed ID: 32870388
[TBL] [Abstract][Full Text] [Related]
38. Activated hepatic stellate cells secrete periostin to induce stem cell-like phenotype of residual hepatocellular carcinoma cells after heat treatment.
Zhang R; Yao RR; Li JH; Dong G; Ma M; Zheng QD; Gao DM; Cui JF; Ren ZG; Chen RX
Sci Rep; 2017 May; 7(1):2164. PubMed ID: 28526827
[TBL] [Abstract][Full Text] [Related]
39. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
Das BK; Choukimath SM; Gadad PC
Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatic analysis of RHO family of GTPases identifies RAC1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma.
Bayo J; Fiore EJ; Dominguez LM; Cantero MJ; Ciarlantini MS; Malvicini M; Atorrasagasti C; Garcia MG; Rossi M; Cavasotto C; Martinez E; Comin J; Mazzolini GD
Gut; 2021 Jul; 70(7):1362-1374. PubMed ID: 33106353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]